Novo Nordisk's Phase 3 trial of ziltivekimab, a drug being studied for cardiovascular risk reduction, did not meet its primary endpoint, sending shares lower an

Replimune shares swung sharply as an FDA panel gave a supportive vote on its melanoma therapy IGNYTE data, but FDA staff documents raised concerns about approva

Capricor Therapeutics shares collapsed after an FDA advisory committee and agency staff raised doubts about the efficacy of its lead candidate deramiocel, trigg

Apnimed went public with a $192 million IPO to advance what could become the first oral treatment for obstructive sleep apnea, a condition currently dominated b

South Korean regulators are moving to flag Novo Nordisk's Wegovy and Eli Lilly's Mounjaro for potential abuse as demand for weight-loss drugs drives a sharp inc

A report claims AstraZeneca is pursuing a $400 billion merger with Bristol Myers Squibb, twelve years after it rejected a takeover approach from Pfizer, which w

Intellia Therapeutics stock jumped overnight as retail sentiment peaked ahead of the first-ever Phase 3 data readout for a CRISPR-based gene-editing therapy.

Viking Therapeutics CEO argued its investigational obesity drug offers a differentiated profile versus GLP-1 competitors, though VKTX stock lagged GLP-1 peers i

AbbVie won FDA approval for a new treatment targeting a rare hematologic cancer, boosting ABBV shares.

SK Pharmteco finished construction of a plant for obesity-drug active pharmaceutical ingredients, positioning itself to compete with Samsung in the peptide cont

The FDA approved Pfizer's palbociclib for maintenance treatment of HR-positive, HER2-positive breast cancer, expanding the label for the CDK4/6 inhibitor.

Sellas Life Sciences shares reached a multi-year high as its Phase 3 trial for an acute myeloid leukemia drug approaches final data, with analysts projecting fu

A U.S. Senate committee will hold hearings on how the biotechnology sector can strengthen national health security and supply chain resilience.

The Department of Veterans Affairs began a nationwide clinical trial testing GLP-1 medications as a treatment for alcohol use disorder in veterans.

South Korean drug price reduction policies are causing strain among pharmacies and prompting the pharmaceutical industry to call for more predictable, innovatio

The FDA granted fast-track designation to psychedelic therapy programs following an executive order from President Trump, lifting shares of companies like Compa

India's drug price regulator sent demand notices to 103 pharmaceutical companies alleging overcharging on medicines, intensifying pricing scrutiny in the Indian

The FDA expanded approval of MannKind's Afrezza inhaled insulin to include pediatric patients, sending MNKD shares higher.